Coronary Stents Market (Bare Metal Stents, Drug Eluting Stents and Bio-absorbable Stents) - Global Industry Analysis, Size, Share, Pipeline Overview, Growth, Trends and Forecast, 2013 - 2019 - KHGI-TV/KWNB-TV/KHGI-CD-Grand Island, Kearney, Hastings

Coronary Stents Market (Bare Metal Stents, Drug Eluting Stents and Bio-absorbable Stents) - Global Industry Analysis, Size, Share, Pipeline Overview, Growth, Trends and Forecast, 2013 - 2019

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Reportlinker

NEW YORK, May 29, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Coronary Stents Market (Bare Metal Stents, Drug Eluting Stents and Bio-absorbable Stents) - Global Industry Analysis, Size, Share, Pipeline Overview, Growth, Trends and Forecast, 2013 - 2019

http://www.reportlinker.com/p02126615/Coronary-Stents-Market-Bare-Metal-Stents-Drug-Eluting-Stents-and-Bio-absorbable-Stents---Global-Industry-Analysis-Size-Share-Pipeline-Overview-Growth-Trends-and-Forecast-2013---2019.html

This report studies the current as well as future prospects of the coronary stents market globally. The market for coronary stents is categorized into three major segments, namely, bare metal stents (BMS), drug eluting stents (DES) and bio-absorbable stents. Each of the market segments has been extensively analyzed on the basis of their commercial existence, efficacy, sales revenue and geographic presence. The market size and forecast in terms of USD million for each product type has been provided for the period 2011 to 2019. The report also provides compounded annual growth rate (CAGR %) for each market segment for the forecast period 2013 to 2019, considering 2012 as the base year.

The global coronary stents market has been categorized into four geographical regions - North America, Europe, Asia-Pacific, and Rest of the World (RoW). The market sizes and forecasts for each of these regions have been provided for the period 2011 to 2019 along with CAGR (%) for the forecast period 2013 to 2019. The research study also incorporates the competitive scenario in these regions. A detailed qualitative analysis of the factors responsible for driving and restraining growth of the global coronary stents market and future opportunities has been provided in the market overview section. This section of the report also deals with market attractiveness analysis, Porter's five forces analysis and key players' market share analysis in 2012 for the global coronary stents market.

A list of recommendations has been provided for new entrants as well as existing market players to help them establish a strong presence in the market and increase their market share. The report also comprises a section on pipeline overview for this market that includes qualitative analysis for various coronary stents currently under phase II, III & IV clinical trials, which are expected to be launched during the forecast period.

The report also profiles major players of the global coronary stents market on the basis of various attributes such as company overview, financial overview, product portfolio, business strategies and recent developments. The major players profiled in this report include Abbott Laboratories, Inc., Boston Scientific Corporation, Medtronic, Inc., Johnson & Johnson, Terumo Corporation, B. Braun Melsungen AG, and C. R. Bard, Inc., Cook Medical, Inc., amg International GmbH, Biotronik SE & Co. KG, Stentys SA and MicroPort Scientific Corporation.

The global coronary stents market is segmented as follows:

Coronary Stents Market, by Product Type


Bare Metal Stents
Drug Eluting Stents
Bio-absorbable Stents

Coronary Stents Market, by Geography

North America
Europe
Asia-Pacific
Rest of the World (RoW)

Table of Content

Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Coronary Stents Market
2.2 Comparative Analysis: Global Coronary Stents Market, by Geography, 2012 & 2019 (Value %)

Chapter 3 Global Coronary Stents Market Overview
3.1 Introduction
3.2 Market Drivers
3.2.1 Increasing Prevalence of Coronary Artery Diseases (CADs)
3.2.2 Rise in Global Obesity Rates
3.2.3 Aging Population
3.2.4 Increasing Uptake of Technologically Advanced Coronary Stents like Bio-absorbable Stents
3.3 Market Restraints
3.3.1 High Product Cost
3.3.2 Lack of Efficient Reimbursement System
3.3.3 High Risk of In-stent and Late-stent Restenosis and Thrombosis
3.4 Market Opportunities
3.4.1 Novel Technologies in Clinical Trials will Address Various Unmet Needs of the Patient Pool
3.4.2 High Growth Opportunities in the Emerging Markets of APAC, LATAM and Africa
3.5 Porter's Five Forces Analysis: Global Coronary Stents Market
3.5.1 Bargaining Power of Suppliers
3.5.2 Bargaining Power of Buyers
3.5.3 Threat of Substitutes
3.5.4 Threat of New Entrants
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis: Global Coronary Stents Market, by Geography
3.7 Competitive Landscape
3.7.1 Market Share Analysis: Global Coronary Stents Market, 2012 (Value %)

Chapter 4 Global Coronary Stents Market, by Product Type
4.1 Overview
4.1.1 Coronary Stents: Key Brands by Manufacturer
4.1.2 Global Coronary Stents Market Revenue, by Product Type, 2011 – 2019 (USD Million)
4.1.3 Comparative Analysis: Global Coronary Stents Market, by Product Type, 2012 & 2019 (Value %)
4.2 Bare Metal Stents
4.2.1 Bare Metal Stents: Key Brands by Manufacturer
4.2.2 Global Bare Metal Stents Market Revenue, 2011 – 2019 (USD Million)
4.3 Drug Eluting Stents
4.3.1 Drug Eluting Stents: Key Brands by Manufacturer
4.3.2 Global Drug Eluting Stents Market Revenue, 2011 – 2019 (USD Million)
4.4 Bio-absorbable Stents
4.4.1 Bio-absorbable Stents: Key Brands by Manufacturer
4.4.2 Global Bio-absorbable Stents Market Revenue, 2011 – 2019 (USD Million)

Chapter 5 Global Coronary Stents Market: Pipeline Overview
5.1 Overview
5.2 CORACTO
5.3 EXCELLA II and EXCELLA BD
5.4 DESolve Nx and DESolve FIM
5.5 ZoMaxx I and ZoMaxx II
5.6 ABSORB STEMI
5.7 BioFreedom
5.8 TAXUS PERSEUS
5.9 BioNIR

Chapter 6 Global Coronary Stents Market, by Geography
6.1 Overview
6.1.1 Global Coronary Stents Market Revenue, by Geography, 2011 – 2019 (USD Million)
6.2 North America
6.2.1 North America Coronary Stents Market Revenue, 2011 - 2019 (USD Million)
6.3 Europe
6.3.1 Europe Coronary Stents Market Revenue, 2011 - 2019 (USD Million)
6.4 Asia-Pacific
6.4.1 Asia-Pacific Coronary Stents Market Revenue, 2011 - 2019 (USD Million)
6.5 Rest of the World (RoW)
6.5.1 RoW Coronary Stents Market Revenue, 2011 - 2019 (USD Million)

Chapter 7 Recommendations
7.1 Investing in Research and Development of Technologically Advanced Products with Additional Benefits
7.2 Targeting Emerging Markets such as India, China, Brazil, Mexico, Russia and South Africa
7.3 Emphasis on Price Control

Chapter 8 Company Profiles
8.1 Abbott Laboratories, Inc.
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.5 Recent Developments
8.2 amg International GmbH
8.2.1 Company Overview
8.2.2 Financial Overview
8.2.3 Product Portfolio
8.2.4 Business Strategies
8.2.5 Recent Developments
8.3 B. Braun Melsungen AG
8.3.1 Company Overview
8.3.2 Financial Overview
8.3.3 Product Portfolio
8.3.4 Business Strategies
8.3.5 Recent Developments
8.4 Biotronik SE & Co. KG
8.4.1 Company Overview
8.4.2 Financial Overview
8.4.3 Product Portfolio
8.4.4 Business Strategies
8.4.5 Recent Developments
8.5 Boston Scientific Corporation
8.5.1 Company Overview
8.5.2 Financial Overview
8.5.3 Product Portfolio
8.5.4 Business Strategies
8.5.5 Recent Developments
8.6 C. R. Bard, Inc.
8.6.1 Company Overview
8.6.2 Financial Overview
8.6.3 Product Portfolio
8.6.4 Business Strategies
8.6.5 Recent Developments
8.7 Cook Medical, Inc.
8.7.1 Company Overview
8.7.2 Financial Overview
8.7.3 Product Portfolio
8.7.4 Business Strategies
8.7.5 Recent Developments
8.8 Johnson & Johnson
8.8.1 Company Overview
8.8.2 Financial Overview
8.8.3 Product Portfolio
8.8.4 Business Strategies
8.8.5 Recent Developments
8.9 Medtronic, Inc.
8.9.1 Company Overview
8.9.2 Financial Overview
8.9.3 Product Portfolio
8.9.4 Business Strategies
8.9.5 Recent Developments
8.10 MicroPort Scientific Corporation
8.10.1 Company Overview
8.10.2 Financial Overview
8.10.3 Product Portfolio
8.10.4 Business Strategies
8.10.5 Recent Developments
8.11 STENTYS SA
8.11.1 Company Overview
8.11.2 Financial Overview
8.11.3 Product Portfolio
8.11.4 Business Strategies
8.11.5 Recent Developments
8.12 Terumo Corporation
8.12.1 Company Overview
8.12.2 Financial Overview
8.12.3 Product Portfolio
8.12.4 Business Strategies
8.12.5 Recent Developments

LIST OF FIGURES

FIG. 1 Coronary Stents: Market Segmentation
FIG. 2 Global Coronary Stents Market, by Product Type, 2012 (USD Million)
FIG. 3 Comparative Analysis: Global Coronary Stents Market, by Geography, 2012 & 2019 (Value %)
FIG. 4 Porter's Five Forces Analysis: Global Coronary Stents Market
FIG. 5 Market Attractiveness Analysis: Global Coronary Stents Market, by Geography
FIG. 6 Market Share by Key Players: Global Coronary Stents Market, 2012 (Value %)
FIG. 7 Comparative Analysis: Global Coronary Stents Market, by Product Type, 2012 & 2019 (Value %)
FIG. 8 Global Bare Metal Stents Market Revenue, 2011 – 2019 (USD Million)
FIG. 9 Global Drug Eluting Stents Market Revenue, 2011 – 2019 (USD Million)
FIG. 10 Global Bio-absorbable Stents Market Revenue, 2011 – 2019 (USD Million)
FIG. 11 North America Coronary Stents Market Revenue, 2011 – 2019 (USD Million)
FIG. 12 Europe Coronary Stents Market Revenue, 2011 – 2019 (USD Million)
FIG. 13 Asia-Pacific Coronary Stents Market Revenue, 2011 – 2019 (USD Million)
FIG. 14 RoW Coronary Stents Market Revenue, 2011 – 2019 (USD Million)
FIG. 15 Abbott Laboratories, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 16 B. Braun Melsungen AG: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 17 Boston Scientific Corporation: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 18 C. R. Bard, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 19 Johnson & Johnson: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 20 Medtronic, Inc.: Annual Revenue, 2010 - 2012 (USD Million)
FIG. 21 MicroPort Scientific Corporation: Annual Revenue, 2010 - 2012 (USD Million)
FIG. 22 STENTYS SA: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 23 Terumo Corporation: Annual Revenue, 2010 – 2012 (USD Million)

LIST OF TABLES

TABLE 1 Market Snapshot: Global Coronary Stents Market
TABLE 2 Coronary Stents: Key Brands by Manufacturer
TABLE 3 Global Coronary Stents Market Revenue, by Product Type, 2011 – 2019 (USD Million)
TABLE 4 Bare Metal Stents: Key Brands by Manufacturer
TABLE 5 Drug Eluting Stents: Key Brands by Manufacturer
TABLE 6 Bio-absorbable Stents: Key Brands by Manufacturer
TABLE 7 Global Coronary Stents Market Revenue, by Geography, 2011 – 2019 (USD Million)

To order this report: Coronary Stents Market (Bare Metal Stents, Drug Eluting Stents and Bio-absorbable Stents) - Global Industry Analysis, Size, Share, Pipeline Overview, Growth, Trends and Forecast, 2013 - 2019
http://www.reportlinker.com/p02126615/Coronary-Stents-Market-Bare-Metal-Stents-Drug-Eluting-Stents-and-Bio-absorbable-Stents---Global-Industry-Analysis-Size-Share-Pipeline-Overview-Growth-Trends-and-Forecast-2013---2019.html

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
General and news information or questions:
Across the Midlands Information:
events@nebraska.tv
Comments: comments@nebraska.tv
News:
news@nebraska.tv
Phone: 308-743-2494
News Fax: 308-743-2660
All content © Copyright 2000 - 2014 WorldNow and NTV. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.